» Articles » PMID: 2693209

Characterization of Triosephosphate Isomerase Mutants with Reduced Enzyme Activity in Mus Musculus

Overview
Journal Genetics
Specialty Genetics
Date 1989 Dec 1
PMID 2693209
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Four heterozygous triosephosphate isomerase (TPI) mutants with approximately 50% reduced activity in blood compared to wild type were detected in offspring of 1-ethyl-1-nitrosourea treated male mice. Breeding experiments displayed an autosomal, dominant mode of inheritance for the mutations. All mutations were found to be homozygous lethal at an early postimplantation stage of embryonic development, probably due to a total lack of TPI activity and consequently to the inability to utilize glucose as a source of metabolic energy. Although activity alteration was also found in liver, lung, kidney, spleen, heart, brain and muscle the TPI deficiency in heterozygotes has no influence on the following physiological traits: hematological parameters, plasma glucose, glucose consumption of blood cells, body weight and organo-somatic indices of liver, spleen, heart, kidney and lung. Biochemical investigations of TPI in the four mutant lines indicated no difference of physicochemical properties compared to the wild type. Results from immunoinactivation assays indicate that the decrease of enzyme activity corresponds to a decrease in the level of an immunologically active moiety. It is suggested that the mutations have affected the Tpi-1 structural locus and resulted in alleles which produce no detectable enzyme activity and no immunologically cross-reacting material. The study furthermore suggests one functional TPI gene per haploid genome in the erythrocyte and seven other tested organs of the mouse.

Citing Articles

Key glycometabolism during oocyte maturation and early embryonic development.

Zhang Y, Li T, Wang Y, Yu Y Reproduction. 2025; 169(3).

PMID: 39846956 PMC: 11840835. DOI: 10.1530/REP-24-0275.


Characterization of genetically modified mice for phosphoglycerate mutase, a vitally-essential enzyme in glycolysis.

Mikawa T, Shibata E, Shimada M, Ito K, Ito T, Kanda H PLoS One. 2021; 16(4):e0250856.

PMID: 33914812 PMC: 8084212. DOI: 10.1371/journal.pone.0250856.


Comparative Transcriptome Analysis of Reveals That Triosephosphate Isomerase-Like Genes Play an Important Role During Decapod Iridescent Virus 1 Infection.

Liao X, Wang C, Wang B, Qin H, Hu S, Wang P Front Immunol. 2020; 11:1904.

PMID: 32983114 PMC: 7485339. DOI: 10.3389/fimmu.2020.01904.


Low catalytic activity is insufficient to induce disease pathology in triosephosphate isomerase deficiency.

Segal J, Mulleder M, Kruger A, Adler T, Scholze-Wittler M, Becker L J Inherit Metab Dis. 2019; 42(5):839-849.

PMID: 31111503 PMC: 7887927. DOI: 10.1002/jimd.12105.


An essential developmental function for murine phosphoglycolate phosphatase in safeguarding cell proliferation.

Segerer G, Hadamek K, Zundler M, Fekete A, Seifried A, Mueller M Sci Rep. 2016; 6:35160.

PMID: 27731369 PMC: 5059750. DOI: 10.1038/srep35160.


References
1.
Charles D, Pretsch W . Linear dose-response relationship of erythrocyte enzyme-activity mutations in offspring of ethylnitrosourea-treated mice. Mutat Res. 1987; 176(1):81-91. DOI: 10.1016/0027-5107(87)90255-7. View

2.
Rosa R, Prehu M, Calvin M, Badoual J, Alix D, Girod R . Hereditary triose phosphate isomerase deficiency: seven new homozygous cases. Hum Genet. 1985; 71(3):235-40. DOI: 10.1007/BF00284582. View

3.
LOWRY O, ROSEBROUGH N, FARR A, RANDALL R . Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1):265-75. View

4.
Schneider A, Valentine W, Hattori M, HEINS Jr H . HEREDITARY HEMOLYTIC ANEMIA WITH TRIOSEPHOSPHATE ISOMERASE DEFICIENCY. N Engl J Med. 1965; 272:229-35. DOI: 10.1056/NEJM196502042720503. View

5.
Brinster R . Carbon dioxide production from glucose by the preimplantation mouse embryo. Exp Cell Res. 1967; 47(1):271-7. DOI: 10.1016/0014-4827(67)90230-3. View